Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination treatment showed a higher response rate but no significant survival benefits.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Early diagnosis and treatment of TPP can prevent complications.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

Minoxidil can cause heart muscle damage in dogs.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

miR-150 helps blood vessel cells develop and speeds up blood clot healing.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.